University Of Vermont Medical Center Dialysis St. Albans is a medicare approved dialysis facility center in Saint Albans, Vermont and it has 9 dialysis stations. It is located in Franklin county at 7 Crest Road, Suite 78, Saint Albans, VT, 05478. You can reach out to the office of University Of Vermont Medical Center Dialysis St. Albans at (802) 847-5008. This dialysis clinic is run as an Independent entity i.e it is not owned by any chain organization. University Of Vermont Medical Center Dialysis St. Albans has the following ownership type - Non-Profit. It was first certified by medicare in May, 1997. The medicare id for this facility is 473502 and it accepts patients under medicare ESRD program.
| Name | University Of Vermont Medical Center Dialysis St. Albans |
|---|---|
| Location | 7 Crest Road, Suite 78, Saint Albans, Vermont |
| No. of Dialysis Stations | 9 |
| Medicare ID | 473502 |
| Managed By | Independent |
| Ownership Type | Non-Profit |
| Late Shifts | No |
| 7 Crest Road, Suite 78, Saint Albans, Vermont, 05478 | |
| (802) 847-5008 | |
News Archive
The U.S. Food and Drug Administration today issued final guidance for people who wish to comment during the agency's advisory committee meetings. The guidance provides instructions on how to request a time to speak and how FDA staff should respond to requests to speak at the meetings.
Conifer Revenue Cycle Solutions, Inc., President Stephen M. Mooney will discuss how hospitals and healthcare systems can improve their financial performance in the current economic downturn during an upcoming executive webinar, "Revenue Cycle: How to Maximize Patient Collections."
As adults age, they accumulate a number of medications for chronic conditions. Older patients take anywhere between 5-15 medications per year, which increases the risk that some of the drugs will counteract each other.
Synovis Life Technologies, Inc., has received Food and Drug Administration 510(k) marketing clearance for its Flow Coupler®, an innovative extension of the company's well-established Microvascular Anastomotic Coupler used in several surgical procedures to connect small blood vessels more quickly and with equal or greater reliability than hand suturing. The Flow Coupler incorporates Doppler technology to immediately measure blood flow after connecting the small blood vessels.
› Verified 4 days ago
| NPI Number | 1841234283 |
| Doing Business As | University Of Vermont Medical Center Inc |
| Address | 92 Fairfield St St Albans, Vermont, 05478 |
| Phone Number | (802) 847-0000 |
News Archive
The U.S. Food and Drug Administration today issued final guidance for people who wish to comment during the agency's advisory committee meetings. The guidance provides instructions on how to request a time to speak and how FDA staff should respond to requests to speak at the meetings.
Conifer Revenue Cycle Solutions, Inc., President Stephen M. Mooney will discuss how hospitals and healthcare systems can improve their financial performance in the current economic downturn during an upcoming executive webinar, "Revenue Cycle: How to Maximize Patient Collections."
As adults age, they accumulate a number of medications for chronic conditions. Older patients take anywhere between 5-15 medications per year, which increases the risk that some of the drugs will counteract each other.
Synovis Life Technologies, Inc., has received Food and Drug Administration 510(k) marketing clearance for its Flow Coupler®, an innovative extension of the company's well-established Microvascular Anastomotic Coupler used in several surgical procedures to connect small blood vessels more quickly and with equal or greater reliability than hand suturing. The Flow Coupler incorporates Doppler technology to immediately measure blood flow after connecting the small blood vessels.
› Verified 4 days ago
| Dialysis patients with Hemoglobin data | 26 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 15 |
News Archive
The U.S. Food and Drug Administration today issued final guidance for people who wish to comment during the agency's advisory committee meetings. The guidance provides instructions on how to request a time to speak and how FDA staff should respond to requests to speak at the meetings.
Conifer Revenue Cycle Solutions, Inc., President Stephen M. Mooney will discuss how hospitals and healthcare systems can improve their financial performance in the current economic downturn during an upcoming executive webinar, "Revenue Cycle: How to Maximize Patient Collections."
As adults age, they accumulate a number of medications for chronic conditions. Older patients take anywhere between 5-15 medications per year, which increases the risk that some of the drugs will counteract each other.
Synovis Life Technologies, Inc., has received Food and Drug Administration 510(k) marketing clearance for its Flow Coupler®, an innovative extension of the company's well-established Microvascular Anastomotic Coupler used in several surgical procedures to connect small blood vessels more quickly and with equal or greater reliability than hand suturing. The Flow Coupler incorporates Doppler technology to immediately measure blood flow after connecting the small blood vessels.
› Verified 4 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 44 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 362 |
| Percentage of adult patients getting regular hemodialysis at the center | 92 |
News Archive
The U.S. Food and Drug Administration today issued final guidance for people who wish to comment during the agency's advisory committee meetings. The guidance provides instructions on how to request a time to speak and how FDA staff should respond to requests to speak at the meetings.
Conifer Revenue Cycle Solutions, Inc., President Stephen M. Mooney will discuss how hospitals and healthcare systems can improve their financial performance in the current economic downturn during an upcoming executive webinar, "Revenue Cycle: How to Maximize Patient Collections."
As adults age, they accumulate a number of medications for chronic conditions. Older patients take anywhere between 5-15 medications per year, which increases the risk that some of the drugs will counteract each other.
Synovis Life Technologies, Inc., has received Food and Drug Administration 510(k) marketing clearance for its Flow Coupler®, an innovative extension of the company's well-established Microvascular Anastomotic Coupler used in several surgical procedures to connect small blood vessels more quickly and with equal or greater reliability than hand suturing. The Flow Coupler incorporates Doppler technology to immediately measure blood flow after connecting the small blood vessels.
› Verified 4 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at University Of Vermont Medical Center Dialysis St. Albans with elevated calcium levels.
| Patients with hypercalcemia | 46 |
| Hypercalcemia patient months | 399 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | 1 |
| Patients with Serumphosphor | 48 |
| Patients with Serumphosphor less than 3.5 mg/dL | 5 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 24 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 35 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 25 |
| Patients with Serumphosphor greater than 7 mg/dL | 12 |
News Archive
The U.S. Food and Drug Administration today issued final guidance for people who wish to comment during the agency's advisory committee meetings. The guidance provides instructions on how to request a time to speak and how FDA staff should respond to requests to speak at the meetings.
Conifer Revenue Cycle Solutions, Inc., President Stephen M. Mooney will discuss how hospitals and healthcare systems can improve their financial performance in the current economic downturn during an upcoming executive webinar, "Revenue Cycle: How to Maximize Patient Collections."
As adults age, they accumulate a number of medications for chronic conditions. Older patients take anywhere between 5-15 medications per year, which increases the risk that some of the drugs will counteract each other.
Synovis Life Technologies, Inc., has received Food and Drug Administration 510(k) marketing clearance for its Flow Coupler®, an innovative extension of the company's well-established Microvascular Anastomotic Coupler used in several surgical procedures to connect small blood vessels more quickly and with equal or greater reliability than hand suturing. The Flow Coupler incorporates Doppler technology to immediately measure blood flow after connecting the small blood vessels.
› Verified 4 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 44 |
| Patient months included in arterial venous fistula and catheter summaries | 329 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 74 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 13 |
News Archive
The U.S. Food and Drug Administration today issued final guidance for people who wish to comment during the agency's advisory committee meetings. The guidance provides instructions on how to request a time to speak and how FDA staff should respond to requests to speak at the meetings.
Conifer Revenue Cycle Solutions, Inc., President Stephen M. Mooney will discuss how hospitals and healthcare systems can improve their financial performance in the current economic downturn during an upcoming executive webinar, "Revenue Cycle: How to Maximize Patient Collections."
As adults age, they accumulate a number of medications for chronic conditions. Older patients take anywhere between 5-15 medications per year, which increases the risk that some of the drugs will counteract each other.
Synovis Life Technologies, Inc., has received Food and Drug Administration 510(k) marketing clearance for its Flow Coupler®, an innovative extension of the company's well-established Microvascular Anastomotic Coupler used in several surgical procedures to connect small blood vessels more quickly and with equal or greater reliability than hand suturing. The Flow Coupler incorporates Doppler technology to immediately measure blood flow after connecting the small blood vessels.
› Verified 4 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 43 |
| Hospitalization Rate in facility | 124.3 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 245.1 |
| Hospitalization Rate: Lower Confidence Limit | 66.1 |
News Archive
The U.S. Food and Drug Administration today issued final guidance for people who wish to comment during the agency's advisory committee meetings. The guidance provides instructions on how to request a time to speak and how FDA staff should respond to requests to speak at the meetings.
Conifer Revenue Cycle Solutions, Inc., President Stephen M. Mooney will discuss how hospitals and healthcare systems can improve their financial performance in the current economic downturn during an upcoming executive webinar, "Revenue Cycle: How to Maximize Patient Collections."
As adults age, they accumulate a number of medications for chronic conditions. Older patients take anywhere between 5-15 medications per year, which increases the risk that some of the drugs will counteract each other.
Synovis Life Technologies, Inc., has received Food and Drug Administration 510(k) marketing clearance for its Flow Coupler®, an innovative extension of the company's well-established Microvascular Anastomotic Coupler used in several surgical procedures to connect small blood vessels more quickly and with equal or greater reliability than hand suturing. The Flow Coupler incorporates Doppler technology to immediately measure blood flow after connecting the small blood vessels.
› Verified 4 days ago
The rate of readmission show you whether patients who were being treated regularly at University Of Vermont Medical Center Dialysis St. Albans were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 13.9 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 29.3 |
| Readmission Rate: Lower Confidence Limit | 4.8 |
News Archive
The U.S. Food and Drug Administration today issued final guidance for people who wish to comment during the agency's advisory committee meetings. The guidance provides instructions on how to request a time to speak and how FDA staff should respond to requests to speak at the meetings.
Conifer Revenue Cycle Solutions, Inc., President Stephen M. Mooney will discuss how hospitals and healthcare systems can improve their financial performance in the current economic downturn during an upcoming executive webinar, "Revenue Cycle: How to Maximize Patient Collections."
As adults age, they accumulate a number of medications for chronic conditions. Older patients take anywhere between 5-15 medications per year, which increases the risk that some of the drugs will counteract each other.
Synovis Life Technologies, Inc., has received Food and Drug Administration 510(k) marketing clearance for its Flow Coupler®, an innovative extension of the company's well-established Microvascular Anastomotic Coupler used in several surgical procedures to connect small blood vessels more quickly and with equal or greater reliability than hand suturing. The Flow Coupler incorporates Doppler technology to immediately measure blood flow after connecting the small blood vessels.
› Verified 4 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at University Of Vermont Medical Center Dialysis St. Albans get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .38 (As Expected) |
| SIR: Upper Confidence Limit | 1.86 |
| SIR: Lower Confidence Limit | .02 |
News Archive
The U.S. Food and Drug Administration today issued final guidance for people who wish to comment during the agency's advisory committee meetings. The guidance provides instructions on how to request a time to speak and how FDA staff should respond to requests to speak at the meetings.
Conifer Revenue Cycle Solutions, Inc., President Stephen M. Mooney will discuss how hospitals and healthcare systems can improve their financial performance in the current economic downturn during an upcoming executive webinar, "Revenue Cycle: How to Maximize Patient Collections."
As adults age, they accumulate a number of medications for chronic conditions. Older patients take anywhere between 5-15 medications per year, which increases the risk that some of the drugs will counteract each other.
Synovis Life Technologies, Inc., has received Food and Drug Administration 510(k) marketing clearance for its Flow Coupler®, an innovative extension of the company's well-established Microvascular Anastomotic Coupler used in several surgical procedures to connect small blood vessels more quickly and with equal or greater reliability than hand suturing. The Flow Coupler incorporates Doppler technology to immediately measure blood flow after connecting the small blood vessels.
› Verified 4 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether University Of Vermont Medical Center Dialysis St. Albans's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 38 |
| Transfusion Rate in facility | 3.5 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 120.7 |
| Transfusion Rate: Lower Confidence Limit | .2 |
News Archive
The U.S. Food and Drug Administration today issued final guidance for people who wish to comment during the agency's advisory committee meetings. The guidance provides instructions on how to request a time to speak and how FDA staff should respond to requests to speak at the meetings.
Conifer Revenue Cycle Solutions, Inc., President Stephen M. Mooney will discuss how hospitals and healthcare systems can improve their financial performance in the current economic downturn during an upcoming executive webinar, "Revenue Cycle: How to Maximize Patient Collections."
As adults age, they accumulate a number of medications for chronic conditions. Older patients take anywhere between 5-15 medications per year, which increases the risk that some of the drugs will counteract each other.
Synovis Life Technologies, Inc., has received Food and Drug Administration 510(k) marketing clearance for its Flow Coupler®, an innovative extension of the company's well-established Microvascular Anastomotic Coupler used in several surgical procedures to connect small blood vessels more quickly and with equal or greater reliability than hand suturing. The Flow Coupler incorporates Doppler technology to immediately measure blood flow after connecting the small blood vessels.
› Verified 4 days ago
The rate of mortality show you whether patients who were being treated regularly at University Of Vermont Medical Center Dialysis St. Albans lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 210 |
| Mortality Rate in facility | 17.3 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 24 |
| Mortality Rate: Lower Confidence Limit | 12.1 |
News Archive
The U.S. Food and Drug Administration today issued final guidance for people who wish to comment during the agency's advisory committee meetings. The guidance provides instructions on how to request a time to speak and how FDA staff should respond to requests to speak at the meetings.
Conifer Revenue Cycle Solutions, Inc., President Stephen M. Mooney will discuss how hospitals and healthcare systems can improve their financial performance in the current economic downturn during an upcoming executive webinar, "Revenue Cycle: How to Maximize Patient Collections."
As adults age, they accumulate a number of medications for chronic conditions. Older patients take anywhere between 5-15 medications per year, which increases the risk that some of the drugs will counteract each other.
Synovis Life Technologies, Inc., has received Food and Drug Administration 510(k) marketing clearance for its Flow Coupler®, an innovative extension of the company's well-established Microvascular Anastomotic Coupler used in several surgical procedures to connect small blood vessels more quickly and with equal or greater reliability than hand suturing. The Flow Coupler incorporates Doppler technology to immediately measure blood flow after connecting the small blood vessels.
› Verified 4 days ago
University Of Vermont Medical Center Dialysis St. Albans Location: 7 Crest Road, Suite 78, Saint Albans, Vermont, 05478 Phone: (802) 847-5008 |
News Archive
The U.S. Food and Drug Administration today issued final guidance for people who wish to comment during the agency's advisory committee meetings. The guidance provides instructions on how to request a time to speak and how FDA staff should respond to requests to speak at the meetings.
Conifer Revenue Cycle Solutions, Inc., President Stephen M. Mooney will discuss how hospitals and healthcare systems can improve their financial performance in the current economic downturn during an upcoming executive webinar, "Revenue Cycle: How to Maximize Patient Collections."
As adults age, they accumulate a number of medications for chronic conditions. Older patients take anywhere between 5-15 medications per year, which increases the risk that some of the drugs will counteract each other.
Synovis Life Technologies, Inc., has received Food and Drug Administration 510(k) marketing clearance for its Flow Coupler®, an innovative extension of the company's well-established Microvascular Anastomotic Coupler used in several surgical procedures to connect small blood vessels more quickly and with equal or greater reliability than hand suturing. The Flow Coupler incorporates Doppler technology to immediately measure blood flow after connecting the small blood vessels.
› Verified 4 days ago